Walter and Eliza Hall Institute of Medical Research
OrganisationROR
People
Lead investigator
Lead investigator
Lead investigator
Sources: openalex.org
Trials
Collaborator, Phase 1, Recruiting, 38 people, 18 Mar 2026
Collaborator, Phase 2, Active, not recruiting, 20 people, 23 Oct 2023
Collaborator, Phase 1/2, Recruiting, 18 people, 29 Dec 2022
Collaborator, Phase 4, Completed, 524 people, 21 May 2014
Collaborator, Phase 3, Completed, 2,793 people, 4 Jun 2010
Grants and prizes
National Health and Medical Research Council
Investigator Grants - Emerging Leadership 1 (EL1), Deciphering mechanisms underpinning tobacco-unassociated lung cancer development to improve patient outcomes, 2043233, A$681k, 2026–2030, 1 Jan 2026
National Health and Medical Research Council
Project Grants - Standard Project Grant, BRCA-P: An international randomised phase III study evaluating the RANK ligand inhibitor denosumab for the prevention of breast cancer in BRCA1 mutation carriers, 1140715, A$2.6m, 2018–2022, 1 Jan 2018
National Breast Cancer Foundation
Research Project Grant, Effective breast cancer prevention for BRCA1 carriers, NBCF-effective-breast-cancer-prevention-for-brca1-carriers, 2017, 1 Jan 2017
Sources: openalex.org